Dependent variable | Independent variable entered in the model | Unstandardized coefficient (95% CI) | Standardized coefficient | P value |
---|---|---|---|---|
SF-36v2 (PCS) | Stage of illness | -2.548 (-3.795, -1.302) | -0.212 | 0.000 |
Total bilirubin | -0.060 (-0.096, -0.024) | -0.171 | 0.001 | |
Education attainment | 1.901 (0.687, 3.116) | 0.149 | 0.002 | |
Duration of illness | -0.110 (-0.213, -0.008) | -0.102 | 0.035 | |
SF-36v2 (MCS) | Currently taken anti-viral treatment | -3.895 (-6.147, -1.644) | -0.174 | 0.001 |
Education attainment | 2.180 (0.247, 4.112) | 0.113 | 0.027 | |
Duration of illness | -0.170 (-0.335, -0.006) | -0.104 | 0.043 | |
SF-6D | Currently taken anti-viral treatment | -0.041 (-0.066, -0.016) | -0.164 | 0.001 |
Education attainment | 0.025 (0.003, 0.048) | 0.117 | 0.029 | |
Total bilirubin | -0.001 (-0.001, 0.000) | -0.107 | 0.036 | |
Age | -0.001 (-0.002, 0.000) | -0.095 | 0.076 | |
CLDQ (Overall) | Age | -0.013 (-0.020, -0.006) | -0.182 | 0.000 |
Annual per capita household income | 0.138 (0.038, 0.238) | 0.138 | 0.007 | |
Duration of illness | -0.017 (-0.030, -0.003) | -0.131 | 0.013 | |
Currently taken anti-viral treatment | -0.203 (-0.375, -0.030) | -0.116 | 0.022 |